American University of Beirut Medical Center

Global cancer drug disparities exist between high- and low-income countries, with rising cases and mortality in lower-income regions. High costs and lack of access hinder treatment, compounded by inadequate screening and healthcare infrastructure. Proposed solutions include sharing production secrets, price discrimination, international funding, and cost-effective screening methods to address inequalities.

Global cancer incidence and mortality are rising, especially in low-income countries, due to disparities in access to treatments, screening, and healthcare infrastructure. Newer cancer drugs are costly, and low-income countries spend less on cancer care despite higher drug prices. Solutions include using generics, biosimilars, and universal healthcare coverage.

Vitamin D supplements may lower blood pressure in obese seniors, but higher doses offer no additional benefits, according to a study in the Journal of the Endocrine Society.